Follow the rules. Understand the workflow. Protect access to care.
Source-backed reporting and analysis connected to the companies, capabilities, authorities, and operating domains it affects.
URAC's Health Utilization Management program applies to eligible U.S. organizations and named clinical-review functions. A platform feature, automation rate, or vendor logo does not by itself establish that accreditation scope.
X12's 278 request-and-response transaction carries health-care-services review information between operating parties. It does not decide eligibility, benefits, medical necessity, final claim adjudication, or payment by itself.
The reporting template separates standard and expedited medical-service requests, outcomes, appeals, and decision timing while recommending counts beside percentages so readers can see scale.
The current Da Vinci guide defines a FHIR prior-authorization request and response workflow while preserving the separate X12 mapping, licensing, and regulatory boundary that implementers still have to govern.
The Da Vinci guide uses computable questionnaires, rules, and EHR context to gather payer-requested documentation, but publication of the guide does not prove that a payer connection or decision works in production.
Coverage Requirements Discovery can bring payer requirements into a provider workflow before a request is sent. It does not submit or decide the authorization.
Seven additional HCPCS codes became subject to nationwide prior authorization as a condition of payment, while CMS also introduced an exemption path for qualifying suppliers.
CMS-0062-P would bring drug authorizations into a broader interoperability framework while also proposing updated standards and transaction requirements.
CMS now requires MA organizations to submit information about internal coverage criteria used by the organization or its delegates for Part C prior authorization.
The three Da Vinci implementation guides define connected but distinct stages for discovering requirements, assembling documentation, and exchanging authorization requests and responses.
The federally named version becomes required January 1, 2028 and includes specific electronic prior-authorization transactions alongside broader e-prescribing changes.
